NFKB1 and breast carcinoma: Nobiletin's anticancer effects in MCF‐7 breast cancer cells may be mediated by the p38 mitogen‐activated protein kinase (p38 MAPK), NF‐κβ, and nuclear factor erythroid 2‐related factor 2 (Nrf2) pathways.